Bicycle Therapeutics plc (BCYC) reported Q3 EPS of ($0.96), $0.07 worse than the analyst estimate of ($0.89). Revenue for the quarter came in at $3.04 million versus the consensus estimate of $5.58 million.
Bicycle Therapeutics plc (BCYC) reported Q3 EPS of ($0.96), $0.07 worse than the analyst estimate of ($0.89). Revenue for the quarter came in at $3.04 million versus the consensus estimate of $5.58 million.